In our study, the genes that mutated in more than 20% of the total patients were TP53, RB1, SMAD4, and NOTCH1. In previous reports, TP53 and RB1 mutations were shown to affect up to 90% and up to 65% of SCLC patients, respectively [13]. This evidence concerns the gene SMAD4 and small cell lung carcinoma.